eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-GLUE-Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc GLUE

4.9-0.13(-2.58%)(1D)
Delayed prices by Nasdaqin USD
Invest in Monte Rosa Therapeutics Inc
Today
Create an eToro account to buy GLUE stock on a secure, user-friendly, multi-asset trading platform.
Buy Monte Rosa Therapeutics Inc
Buy Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc GLUE
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
10
Based on analysts who covered GLUE

GLUE Stock Price Chart

‎13.92‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Monte Rosa Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Monte Rosa Therapeutics Inc share price today is 4.9, reflecting a ‎-2.58‎% change over the last 24 hours and ‎6.28‎% over the past week. The current market capitalization of GLUE is 302.63M with an average volume in the last three months of 665003.7. The stock has a P/E ratio of 73.21 and a dividend yield of 0%. With the stock’s beta sitting at 1.7
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
302.63M

Day’s Range
i
Shows the high and low prices of the day.
3.85 - 5.25

52W Range
i
Shows the high and low prices of the last year.
2.92 - 12.31

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
665003.7

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
73.21

Revenue
i
The total income generated by this company’s goods and services last year.
159.49M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
4.92

EPS
i
A company’s total earnings divided by the number of shares it has issued.
0.07

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.7

How can I buy Monte Rosa Therapeutics Inc stocks?

To purchase Monte Rosa Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Monte Rosa Therapeutics Inc (GLUE) page and place an order to buy Monte Rosa Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Monte Rosa Therapeutics Inc
Invest in Monte Rosa Therapeutics Inc
Today
Create an eToro account to buy GLUE stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of GLUE is 4.9.
The average price target for Monte Rosa Therapeutics Inc is 4.9. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Monte Rosa Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Monte Rosa Therapeutics Inc is 302.63M
Based on 2 analysts offering recommendations for GLUE in the last 3 months, the overall consensus is Moderate Buy.
Scroll to top